The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A clinical and translational phase II trial of sequential axitinib and carboplatin/paclitaxel in advanced melanoma.
Alain Patrick Algazi
No relevant relationships to disclose
Edward Cha
No relevant relationships to disclose
Miguel H Pampaloni
No relevant relationships to disclose
Spencer Behr
No relevant relationships to disclose
Brandon Cortez
No relevant relationships to disclose
Anteo Quiroz
No relevant relationships to disclose
Fergus V. Coakley
No relevant relationships to disclose
Songling Liu
No relevant relationships to disclose
Adil Daud
Research Funding - Pfizer